Preparations containing amorphous emodepside

Abstract

The invention relates to preparations comprising amorphous emodepside in a polyvinylpyrrolidone matrix, pharmaceuticals comprising such preparations, and their use against endoparasites in animals or humans.

1 . (canceled) 
     
     
         2 . (canceled) 
     
     
         3 . (canceled) 
     
     
         4 . (canceled) 
     
     
         5 . (canceled) 
     
     
         6 . (canceled) 
     
     
         7 . (canceled) 
     
     
         8 . (canceled) 
     
     
         9 . (canceled) 
     
     
         10 . (canceled) 
     
     
         11 . A method for treating or preventing an endoparasite comprising administering to a human or animal in need thereof an effective amount of a pharmaceutical composition comprising emodepside in a polyvinylpyrrolidone matrix, wherein at least 50% of the emodepside is in an amorphous form. 
     
     
         12 . The method according to  claim 11 , wherein the endoparasite is a helminth selected from Platyhelmintha, Nematoda, Pentastoma and Acanthocephala. 
     
     
         13 . The method according to  claim 12 , wherein the Platyhelmintha is selected from Monogenea, Cestoda and Trematoda.